Brava C8-BDS is a reversed-phase HPLC column based on fully porous, high-purity silica and modified with octyl (C8) groups combined with base deactivation (Base Deactivated Silica) technology. This phase offers moderate hydrophobic retention and significantly reduces silanol interactions, making it ideal for the analysis of basic and polar compounds with improved peak symmetry. Brava C8-BDS is a strong choice for routine reversed-phase applications requiring enhanced selectivity and robustness.
Brava C8-BDS provides reliable, base-deactivated reversed-phase performance – ideal for balanced, high-throughput chromatography involving sensitive or basic analytes.
Octyl (C8) bonded phase with base deactivation (USP L7)
Reduced peak tailing for basic and polar analytes
Faster elution than C18 phases with good selectivity
Stable performance in aqueous-organic mobile phases
Available in 3 µm, 5 µm, and 10 µm particle sizes
Basic pharmaceutical compounds and impurities
Food additives and chemical ingredients
Method development requiring reduced retention and improved peak shape
Routine reversed-phase separations with enhanced reproducibility
| Particle Sizes |
|
|---|---|
| Pore Size | 145 Å |
| Surface Area | 180 m²/g |
| Phase/Modification | C8 |
| Particle Type | |
| Separation Mode | |
| USP Code | |
| Endcapping | Yes |
| Carbonload | 6 % |
| Phase | Material Number |
|---|---|
| Brava C8-BDS, 3 µm | 5204017 |
| Brava C8-BDS, 5 µm | 5204018 |
| Brava C8-BDS, 10 µm | 5204019 |